Latest Innovation News

HighCom Limited has landed a significant A$2.6 million order from the Australian Department of Defence to supply Counter Small Uncrewed Aerial Systems, marking a strategic expansion into counter-drone technology.

SKS Technologies has delivered a robust first half in 2025, showcasing strong revenue growth and a burgeoning project pipeline, underpinned by zero debt and strategic expansion in data centres and traditional electrical services.

BetMakers Technology Group reports a strong FY25 trading update, driven by enhancements to its Apollo racing suite and preparations for the GTX wagering platform launch, signaling robust momentum heading into FY26.

Barton Gold Holdings has kicked off a major drilling campaign at its Tarcoola Gold Project, following extraordinary assay results revealing silver grades as high as 17,600g/t and gold up to 83.6g/t. The program aims to map and expand these high-value zones.

Ventia Services Group Limited delivered strong financial results for 2024, highlighted by a 12.8% rise in NPATA and a record 92% contract renewal rate, while reaffirming growth guidance despite ongoing ACCC proceedings.

Dimerix Limited’s ACTION3 Phase 3 trial for DMX-200 in treating FSGS kidney disease has passed its sixth independent safety review with no concerns, reinforcing the drug’s promising safety profile.

Hawsons Iron Ltd confirms the technical viability of a fully dry processing circuit for its Hawsons Iron Project, promising cost and environmental benefits. An updated prefeasibility study and maiden ore reserves are expected soon.

Argenica Therapeutics has expanded its intellectual property with a new US patent targeting surgically induced strokes, enhancing the commercial potential of its lead drug candidate ARG-007.

Australian Agricultural Company Limited (AACo) reported a robust FY25 operating profit of $58.4 million, driven by increased meat and cattle sales volumes and strategic brand growth despite inflationary pressures.

AFT Pharmaceuticals reported a 6% revenue increase to NZ$208 million in FY25, driven by strong ANZ growth and expanding international presence. The company targets NZ$300 million revenue by FY27 amid ongoing R&D and new product launches.

AFT Pharmaceuticals has reported record revenue of NZD 208 million for FY25, driven by strong Australasian sales and a recovery in Asia and international markets. The company is targeting NZD 300 million in revenue by FY27, supported by an expanded R&D pipeline and ongoing geographic diversification.

WestStar Industrial’s subsidiary SIMPEC has landed a $17 million contract to deliver key construction works for a pioneering lithium refining plant in Western Australia, marking a significant step in Australia’s energy transition.